• ADBiotech corrected terms for its KRW 1 billion convertible bond issue, delaying payment to Nov. 11, 2026, from Nov. 6.
• Maturity moves to Nov. 11, 2029; interest payments switch from quarterly to monthly at an unchanged 6% annual coupon.
• New conversion-price resets apply every seven months, with a KRW 1,400 floor versus the initial KRW 1,999 conversion price.
• The annual call-option premium rises to 6.5% from 6%.
• Added collateral provisions require security equivalent to 120% of the bonds’ registered amount within one month of issuance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADBiotech Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261103000389), on November 04, 2026, and is solely responsible for the information contained therein.